405 related articles for article (PubMed ID: 28560726)
1. Payment Reform and Health Disparities: Changes in Dialysis Modality under the New Medicare Dialysis Payment System.
Turenne M; Baker R; Pearson J; Cogan C; Mukhopadhyay P; Cope E
Health Serv Res; 2018 Jun; 53(3):1430-1457. PubMed ID: 28560726
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal Dialysis Patient Outcomes under the Medicare Expanded Dialysis Prospective Payment System.
Young EW; Kapke A; Ding Z; Baker R; Pearson J; Cogan C; Mukhopadhyay P; Turenne MN
Clin J Am Soc Nephrol; 2019 Oct; 14(10):1466-1474. PubMed ID: 31515234
[TBL] [Abstract][Full Text] [Related]
3. Financial implications to Medicare from changing the dialysis modality mix under the bundled prospective payment system.
Liu FX; Walton SM; Leipold R; Isbell D; Golper TA
Perit Dial Int; 2014; 34(7):749-57. PubMed ID: 25292402
[TBL] [Abstract][Full Text] [Related]
4. Health Insurance and the Use of Peritoneal Dialysis in the United States.
Perez JJ; Zhao B; Qureshi S; Winkelmayer WC; Erickson KF
Am J Kidney Dis; 2018 Apr; 71(4):479-487. PubMed ID: 29277511
[TBL] [Abstract][Full Text] [Related]
5. Using race as a case-mix adjustment factor in a renal dialysis payment system: potential and pitfalls.
Roach JL; Turenne MN; Hirth RA; Wheeler JR; Sleeman KS; Messana JM
Am J Kidney Dis; 2010 Nov; 56(5):928-36. PubMed ID: 20888100
[TBL] [Abstract][Full Text] [Related]
6. Does One Size Fit All With the Effects of Payment Reform? Dialysis Facility Payer Mix and Anemia Management Under the Expanded Medicare Prospective Payment System.
Mukhopadhyay P; Pearson J; Cogan C; Gaber C; Gillespie BW; Turenne M
Med Care; 2019 Aug; 57(8):584-591. PubMed ID: 31295188
[TBL] [Abstract][Full Text] [Related]
7. Effects of physician payment reform on provision of home dialysis.
Erickson KF; Winkelmayer WC; Chertow GM; Bhattacharya J
Am J Manag Care; 2016 Jun; 22(6):e215-23. PubMed ID: 27355909
[TBL] [Abstract][Full Text] [Related]
8. Trends in Peritoneal Dialysis Use in the United States after Medicare Payment Reform.
Sloan CE; Coffman CJ; Sanders LL; Maciejewski ML; Lee SD; Hirth RA; Wang V
Clin J Am Soc Nephrol; 2019 Dec; 14(12):1763-1772. PubMed ID: 31753816
[TBL] [Abstract][Full Text] [Related]
9. Medicare Program; End-Stage Renal Disease Prospective Payment System, Coverage and Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program Bid Surety Bonds, State Licensure and Appeals Process for Breach of Contract Actions, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program and Fee Schedule Adjustments, Access to Care Issues for Durable Medical Equipment; and the Comprehensive End-Stage Renal Disease Care Model. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2016 Nov; 81(214):77834-969. PubMed ID: 27905888
[TBL] [Abstract][Full Text] [Related]
10. Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients.
Shih YC; Guo A; Just PM; Mujais S
Kidney Int; 2005 Jul; 68(1):319-29. PubMed ID: 15954923
[TBL] [Abstract][Full Text] [Related]
11. Blood transfusion practices in dialysis patients in a dynamic regulatory environment.
Hirth RA; Turenne MN; Wilk AS; Wheeler JR; Sleeman KK; Zhang W; Paul MA; Nahra TA; Messana JM
Am J Kidney Dis; 2014 Oct; 64(4):616-21. PubMed ID: 24560166
[TBL] [Abstract][Full Text] [Related]
12. Bundled Payment Reform and Dialysis Facility Closures in ESKD.
Norouzi S; Zhao B; Awan A; Winkelmayer WC; Ho V; Erickson KF
J Am Soc Nephrol; 2020 Mar; 31(3):579-590. PubMed ID: 32019784
[TBL] [Abstract][Full Text] [Related]
13. Renal Dialysis and its Financing.
Borelli M; Paul DP; Skiba M
Hosp Top; 2016; 94(2):33-8. PubMed ID: 27315562
[TBL] [Abstract][Full Text] [Related]
14. Can dialysis patients be accurately identified using healthcare claims data?
Taneja C; Berger A; Inglese GW; Lamerato L; Sloand JA; Wolff GG; Sheehan M; Oster G
Perit Dial Int; 2014; 34(6):643-51. PubMed ID: 24497600
[TBL] [Abstract][Full Text] [Related]
15. Financial implications of choice of dialysis type of the revised Medicare payment system: an economic analysis.
Hornberger J; Hirth RA
Am J Kidney Dis; 2012 Aug; 60(2):280-7. PubMed ID: 22560829
[TBL] [Abstract][Full Text] [Related]
16. Managing oral phosphate binder medication expenditures within the Medicare bundled end-stage renal disease prospective payment system: economic implications for large U.S. dialysis organizations.
Park H; Rascati KL; Keith MS
J Manag Care Spec Pharm; 2015 Jun; 21(6):507-14. PubMed ID: 26011552
[TBL] [Abstract][Full Text] [Related]
17. Home Dialysis in the Prospective Payment System Era.
Lin E; Cheng XS; Chin KK; Zubair T; Chertow GM; Bendavid E; Bhattacharya J
J Am Soc Nephrol; 2017 Oct; 28(10):2993-3004. PubMed ID: 28490435
[TBL] [Abstract][Full Text] [Related]
18. Effect of Medicare dialysis payment reform on use of erythropoiesis stimulating agents.
Swaminathan S; Mor V; Mehrotra R; Trivedi AN
Health Serv Res; 2015 Jun; 50(3):790-808. PubMed ID: 25355431
[TBL] [Abstract][Full Text] [Related]
19. ESRD Policies and the Delivery of Pediatric Long-term Dialysis Care in the United States.
Brewer ED
Am J Kidney Dis; 2021 Feb; 77(2):264-267. PubMed ID: 32920156
[No Abstract] [Full Text] [Related]
20. Medicare's New Prospective Payment System on Facility Provision of Peritoneal Dialysis.
Wang V; Coffman CJ; Sanders LL; Lee SD; Hirth RA; Maciejewski ML
Clin J Am Soc Nephrol; 2018 Dec; 13(12):1833-1841. PubMed ID: 30455323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
